The world’s first targeted vaccine against the Bovine Viral Diarrhea Virus (BVDV), developed by Bioinnovo, was one of 4 finalists in its category among around 1,000 projects submitted at the 13th edition of the Pioneering Solutions Contest from Banco Nación, aimed at SMEs and enterprises….
Knowledge about the impact of this virus on production and control measures to mitigate its effect on the herd was disseminated at the Second International Congress on Bovine Viral Diarrhea Virus (BVDV), convened by Bioinnovo and INTA. The Second International BVDV Congress, held virtually by…
In August, Bioinnovo will host the Second International Congress on Bovine Viral Diarrhea Virus (BVDV), which will be held remotely. Bioinnovo, the public-private company made up of Vetanco and INTA, will host the Second International Congress on BVDV, which will be held online on Monday,…
Bioinnovo has participated in 2021 ISV Annual Virtual Congress by sharing experiences in the development of innovative veterinary vaccines to fight against several diseases, and by introducing the successful case of Vedevax Block, the first subunit recombinant vaccine in the world that has been approved…
The second day of the First International Congress on Bovine Viral Diarrhea Virus (BVDV) was held last Monday, August 2, and dealt with the different available vaccines and vaccination strategies to fight against this virus, responsible for millions of dollars in losses to national farms….
On Monday, July 12 the International Congress of Bovine Viral Diarrhea Virus (BVDV) was initiated addressing the problems raised by the disease in cattle as well as its enormous economic losses and alternatives for its control. Bioinnovo, the public-private company formed by Vetanco and INTA, has organized the First International Congress…
Organized by the American Society of Animal Science (ASAS), the 2021 ASAS-CSAS-SSASAS Annual Meeting & Trade Show will be held on July 14-17 in a hybrid modality. During the event, Bioinnovo representatives will present the studies conducted with Vedevax BLOCK, the first targeted subunit vaccine against…
On Monday, July 12, and August 2, 2021, Bioinnovo organizes the First International Congress of Bovine Viral Diarrhea Virus (BVDV), which will be held virtually. Bioinnovo, a public-private partnership between Vetanco and INTA, is the organizer of the First International Congress of Bovine Viral Diarrhea Virus, to be…
Our specialists participated in the “Conference of Research Workers in Animal Diseases 2020” held virtually last December 5-8. The “Conference of Research Workers in Animal Diseases 2020”, locally known as “CRWAD 2020 Conference” took place last December 5-8 in a virtual modality. Bioinnovo–Vetanco and Vetanco USA specialists…
Bioinnovo, a public-private partnership between INTA and Vetanco S.A., will allocate an important support, granted by the Ministry of Productive Development, to increase the production of Vedevax Block in order to meet local demand and open new international markets. This is the first subunit vaccine…